News

Search:
 Search

Latest News | 6 December 2012

Government Report Details FDA's Progress, Failures in Implementing Improvements

0 Likes

The Department of Health and Human Services' (DHHS) Office of the Inspector General (OIG)is many things: an investigator of programs, a finder of fraud and a recommender of program improvements. A new Read More...


Latest News | 29 June 2012

FDA Meeting on Hip Implants Recommends Against Use

0 Likes

A panel of experts convened on Thursday, 28 June by US regulators has recommended against the use of metal-on-metal hip implants in patients, reports the Associated Press.The hips, cleared for use by Read More...


Latest News | 18 June 2012

Investigation Clears Faulty Implants of Most Serious Safety Concerns

0 Likes

The UK’s Department of Health (DoH) has released its second and final report on the role of regulatory authorities in the proliferation of defective breast implant products manufactured by the Read More...


Latest News | 7 June 2012

European Ombudsman Chides EMA for Transparency Problems

0 Likes

A report from the European Ombudsman calls on the European Medicines Agency (EMA) to increase the transparency surrounding its pediatric medicines testing requirements after finding an inconsistent Read More...


Latest News | 14 May 2012

New Bill Would Subject Regulations to Quadrennial Legislative Review

0 Likes

A new bill proposed in the US House of Representatives would require the Office of Information and Regulatory Affairs (OIRA) to compile a report every four years recommending certain regulatory Read More...


Latest News | 27 April 2012

New US Bioeconomy Blueprint Addresses Regulatory Hurdles for Drugs, Medical Devices

0 Likes

The White House Office of Science and Technology (OST) released its National Bioeconomy Blueprint, which charts the course for the future development of bioscience research in the US and addresses Read More...


RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

New Regulatory Focus Apps for iPad and iPhone